CGC
CGC
NASDAQ · Pharmaceuticals

Canopy Growth Corp

$0.97
+0.01 (+1.50%)
As of Mar 25, 10:04 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.41B
Net Income
-3,133,446,944
Gross Margin
30.3%
Profit Margin
-222.4%
Rev Growth
-19.2%
D/E Ratio
0.67
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 30.3% 30.3% 56.1% 56.1%
Operating Margin -35.2% -31.7% 13.1% 13.7%
Profit Margin -222.4% -211.2% 14.3% 14.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.41B 1.74B 156.52M 143.27M
Gross Profit 426.99M 528.58M 87.74M 80.31M
Operating Income -496,605,165 -553,286,269 20.57M 19.56M
Net Income -3,133,446,944 -3,491,089,687 22.40M 20.41M
Gross Margin 30.3% 30.3% 56.1% 56.1%
Operating Margin -35.2% -31.7% 13.1% 13.7%
Profit Margin -222.4% -211.2% 14.3% 14.3%
Rev Growth -19.2% -19.2% +1.7% +0.2%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 113.91M 113.91M 105.38M 93.00M
Total Equity 170.63M 170.63M 454.44M 415.12M
D/E Ratio 0.67 0.67 0.23 0.22
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -567,458,671 -667,350,504 28.04M 26.75M
Free Cash Flow 15.05M 13.14M